Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)

14 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share as of Q4 2019.
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,849,679 shares of 84,213,667 outstanding shares and own 6.9% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1,250,396 shares), NEA Management Company, LLC (1,219,674 shares), Abingworth LLP (901,943 shares), venBio Partners LLC (875,000 shares), Novo Holdings A/S (740,740 shares), Aisling Capital Management LP (443,596 shares), Tekla Capital Management LLC (275,000 shares), WEDBUSH SECURITIES INC (81,100 shares), IHT Wealth Management, LLC (20,460 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (15,375 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.